Brain spray study probes Insulin's role in psychosis
NCT ID NCT07252752
Summary
This study aims to understand how insulin, a hormone that controls blood sugar, might affect brain chemicals involved in psychosis. Researchers will give a nasal insulin spray to people experiencing their first psychotic episode and to healthy volunteers, then use brain scans to measure changes. The goal is to learn more about the connection between metabolism and psychiatric symptoms, not to provide direct treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FIRST EPISODE PSYCHOSIS (FEP) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Medical University of Vienna
Vienna, 1090, Austria
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.